Evaluation of the effect of oral Clonidine on reducing bleeding during hysterectomy
Phase 3
Recruiting
- Conditions
- hysterectomy.
- Registration Number
- IRCT20211117053086N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Patient informed consent
No pregnancy and use of birth control pills
Absence of systemic diseases and inherited or acquired coagulation disorders
No history of ischemic heart disease
No history of taking anticoagulants that affect bleeding
No smoking and alcohol
Known insensitivity to clonidine
No history of repeated abdominal surgeries and the presence of abdominal adhesions
Exclusion Criteria
Raynaud's syndrome
porphyria
Renal dysfunction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding rate. Timepoint: Immediately after surgery. Method of measurement: Visual estimation scale: The number of normal gases impregnated in blood is multiplied by 10 ml and long gases by 50 ml and the result is added to the volume of suctioned blood. Since this volume is included in the volume of rinsing fluids in the surgical area; It also reduces the amount of fluid consumed and the result is equal to the amount of actual blood loss of the patient.
- Secondary Outcome Measures
Name Time Method